[Editors' Choice] A QuICR test to diagnose Parkinsons disease

Refined conditions permit rapid detection of proteopathic α-synuclein seeds in cerebrospinal fluid from patients with Parkinson’s disease.

Source: Science Translational Medicine - January 13, 2021 Category: Biomedical Science Authors: Davis, A. A. Tags: Editors ' Choice Source Type: research